Skip to main content
Top
Published in: Child's Nervous System 4/2020

Open Access 01-04-2020 | Metastasis | Original Article

Outcomes with respect to extent of surgical resection for pediatric atypical teratoid rhabdoid tumors

Authors: Alexandra Richards, Ronak Ved, Christopher Murphy, Dawn Hennigan, John-Paul Kilday, Ian Kamaly-Asl, Conor Mallucci, Imran Bhatti, Chirag Patel, Paul Leach

Published in: Child's Nervous System | Issue 4/2020

Login to get access

Abstract

Purpose

To evaluate overall survival for atypical teratoid rhabdoid tumors (ATRTs) in relation to extent of surgical resection.

Methods

The neurosurgical tumor databases from three UK Pediatric centers (University Hospital of Wales, Alder Hey and Royal Manchester Children’s Hospital) were analyzed. Patients with a diagnosis of ATRT were identified between 2000 and 2018. Data was collected regarding demographics, extent of resection, complications, and overall survival.

Results

Twenty-four patients diagnosed with ATRT underwent thirty-eight operations. The age range was 20 days to 147 months (median 17.5 months). The most common location for the tumor was the posterior fossa (nine patients; 38%). Six patients (25%) underwent a complete total resection (CTR), seven (29%) underwent a near total resection (NTR), eight (33.3%) underwent a subtotal resection (STR), and three patients (12.5%) had biopsy only. Two-thirds of patients who underwent a CTR are still alive, as of March 2019, compared to 29% in the NTR and 12.5% in the STR groups. Out of the thirty-eight operations, there were a total of twenty-two complications, of which the most common was pseudomeningocele (27%). The extent of surgical resection (p = 0.021), age at surgery (p = 0.00015), and the presence of metastases at diagnosis (0.015) significantly affected overall survival.

Conclusions

Although these patients are a highly vulnerable group, maximal resection is recommended where possible, for the best chance of long-term survival. However, near total resections are likely beneficial when compared with subtotal resections and biopsy alone. Maximal surgical resection should be combined with adjuvant therapies for the best long-term outcomes.
Literature
1.
go back to reference Asmaro K, Arshad M, Massie L, Griffith B, Lee I (2019) Sellar atypical teratoid/Rhabdoid tumor presenting with subarachnoid and intraventricular hemorrhage. World Neurosurg 123:e31–e38CrossRefPubMed Asmaro K, Arshad M, Massie L, Griffith B, Lee I (2019) Sellar atypical teratoid/Rhabdoid tumor presenting with subarachnoid and intraventricular hemorrhage. World Neurosurg 123:e31–e38CrossRefPubMed
3.
go back to reference Beckwith J, Palmer N (1978) Histopathology and prognosis of Wilms tumor results from the first national Wilms’ tumor study. Cancer 41:1937–1948CrossRefPubMed Beckwith J, Palmer N (1978) Histopathology and prognosis of Wilms tumor results from the first national Wilms’ tumor study. Cancer 41:1937–1948CrossRefPubMed
4.
5.
go back to reference Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79PubMed Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79PubMed
6.
go back to reference Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461–3467PubMed Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8:3461–3467PubMed
8.
go back to reference Biswas A, Kashyap L, Kakkar A, Sarkar C, Julka PK (2016) (2016) atypical teratoid/rhabdoid tumors: challenges and search for solutions. Cancer Manag Res 8:115–125CrossRefPubMedPubMedCentral Biswas A, Kashyap L, Kakkar A, Sarkar C, Julka PK (2016) (2016) atypical teratoid/rhabdoid tumors: challenges and search for solutions. Cancer Manag Res 8:115–125CrossRefPubMedPubMedCentral
11.
go back to reference Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW (2009) Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27:385–389. https://doi.org/10.1200/JCO.2008.18.7724 CrossRefPubMedPubMedCentral Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus KJ, Goumnerova L, Ullrich NJ, Kieran MW (2009) Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27:385–389. https://​doi.​org/​10.​1200/​JCO.​2008.​18.​7724 CrossRefPubMedPubMedCentral
12.
go back to reference Dufour C, Beaugrand A, Le Deley MC, Bourdeaut F, André N, Leblond P, Bertozzi AI, Frappaz D, Rialland X, Fouyssac F, Edan C, Grill J, Quidot M, Varlet P (2012) Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 118:3812–3821. https://doi.org/10.1002/cncr.26684 CrossRefPubMed Dufour C, Beaugrand A, Le Deley MC, Bourdeaut F, André N, Leblond P, Bertozzi AI, Frappaz D, Rialland X, Fouyssac F, Edan C, Grill J, Quidot M, Varlet P (2012) Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 118:3812–3821. https://​doi.​org/​10.​1002/​cncr.​26684 CrossRefPubMed
14.
go back to reference Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R, Milano GM, Garrè ML, Donfrancesco A (2009) A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience. J Neuro-Oncol 92:177–183. https://doi.org/10.1007/s11060-008-9750-y CrossRef Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R, Milano GM, Garrè ML, Donfrancesco A (2009) A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience. J Neuro-Oncol 92:177–183. https://​doi.​org/​10.​1007/​s11060-008-9750-y CrossRef
15.
go back to reference Fossey M, Li H, Afzal S, Carret AS, Eisenstat DD, Fleming A, Hukin J, Hawkins C, Jabado N, Johnston D, Brown T, Larouche V, Scheinemann K, Strother D, Wilson B, Zelcer S, Huang A, Bouffet E, Lafay-Cousin L (2017) Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature. J Neuro-Oncol 132:155–162. https://doi.org/10.1007/s11060-016-2353-0 CrossRef Fossey M, Li H, Afzal S, Carret AS, Eisenstat DD, Fleming A, Hukin J, Hawkins C, Jabado N, Johnston D, Brown T, Larouche V, Scheinemann K, Strother D, Wilson B, Zelcer S, Huang A, Bouffet E, Lafay-Cousin L (2017) Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature. J Neuro-Oncol 132:155–162. https://​doi.​org/​10.​1007/​s11060-016-2353-0 CrossRef
16.
go back to reference Gonzales M (2001) The 2000 World Health Organization classification of tumours of the nervous system. J Clin Neurosci 8:1–3CrossRefPubMed Gonzales M (2001) The 2000 World Health Organization classification of tumours of the nervous system. J Clin Neurosci 8:1–3CrossRefPubMed
19.
go back to reference Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Jones DTW, Sturm D, Hermann C, Segura Wang M, Korshunov A, Rhyzova M, Gröbner S, Brabetz S, Chavez L, Bens S, Gröschel S, Kratochwil F, Wittmann A, Sieber L, Geörg C, Wolf S, Beck K, Oyen F, Capper D, van Sluis P, Volckmann R, Koster J, Versteeg R, von Deimling A, Milde T, Witt O, Kulozik AE, Ebinger M, Shalaby T, Grotzer M, Sumerauer D, Zamecnik J, Mora J, Jabado N, Taylor MD, Huang A, Aronica E, Bertoni A, Radlwimmer B, Pietsch T, Schüller U, Schneppenheim R, Northcott PA, Korbel JO, Siebert R, Frühwald MC, Lichter P, Eils R, Gajjar A, Hasselblatt M, Pfister SM, Kool M (2016) Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 29(3):379–393. https://doi.org/10.1016/j.ccell.2016.02.001 CrossRefPubMed Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Jones DTW, Sturm D, Hermann C, Segura Wang M, Korshunov A, Rhyzova M, Gröbner S, Brabetz S, Chavez L, Bens S, Gröschel S, Kratochwil F, Wittmann A, Sieber L, Geörg C, Wolf S, Beck K, Oyen F, Capper D, van Sluis P, Volckmann R, Koster J, Versteeg R, von Deimling A, Milde T, Witt O, Kulozik AE, Ebinger M, Shalaby T, Grotzer M, Sumerauer D, Zamecnik J, Mora J, Jabado N, Taylor MD, Huang A, Aronica E, Bertoni A, Radlwimmer B, Pietsch T, Schüller U, Schneppenheim R, Northcott PA, Korbel JO, Siebert R, Frühwald MC, Lichter P, Eils R, Gajjar A, Hasselblatt M, Pfister SM, Kool M (2016) Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 29(3):379–393. https://​doi.​org/​10.​1016/​j.​ccell.​2016.​02.​001 CrossRefPubMed
20.
go back to reference Kordes U, Gesk S, Frühwald MC, Graf N, Leuschner I, Hasselblatt M, Jeibmann A, Oyen F, Peters O, Pietsch T, Siebert R, Schneppenheim R (2010) Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Genes Chromosom Cancer 49:176–181. https://doi.org/10.1002/gcc.20729 CrossRefPubMed Kordes U, Gesk S, Frühwald MC, Graf N, Leuschner I, Hasselblatt M, Jeibmann A, Oyen F, Peters O, Pietsch T, Siebert R, Schneppenheim R (2010) Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Genes Chromosom Cancer 49:176–181. https://​doi.​org/​10.​1002/​gcc.​20729 CrossRefPubMed
21.
go back to reference Kramm C, Wagner S, Van-Gool S, Schmid H et al (2006) Improved survival after gross total resection of malignant Gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res 26:3773–3780PubMed Kramm C, Wagner S, Van-Gool S, Schmid H et al (2006) Improved survival after gross total resection of malignant Gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res 26:3773–3780PubMed
22.
go back to reference Lafay-Cousin L, Hawkins C, Carret AS, Johnston D, Zelcer S, Wilson B, Jabado N, Scheinemann K, Eisenstat D, Fryer C, Fleming A, Mpofu C, Larouche V, Strother D, Bouffet E, Huang A (2012) Central nervous system atypical teratoid rhabdoid tumours: the Canadian pediatric brain tumour consortium experience. Eur J Cancer 48:353–359. https://doi.org/10.1016/j.ejca.2011.09.005 CrossRefPubMed Lafay-Cousin L, Hawkins C, Carret AS, Johnston D, Zelcer S, Wilson B, Jabado N, Scheinemann K, Eisenstat D, Fryer C, Fleming A, Mpofu C, Larouche V, Strother D, Bouffet E, Huang A (2012) Central nervous system atypical teratoid rhabdoid tumours: the Canadian pediatric brain tumour consortium experience. Eur J Cancer 48:353–359. https://​doi.​org/​10.​1016/​j.​ejca.​2011.​09.​005 CrossRefPubMed
23.
go back to reference Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820CrossRefPubMed Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820CrossRefPubMed
24.
go back to reference Packer RJ, Biegal JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LBSM (2002) Atypical Teratoid/Rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Haematol 24:337–342CrossRef Packer RJ, Biegal JA, Blaney S, Finlay J, Geyer JR, Heideman R, Hilden J, Janss AJ, Kun L, Vezina G, Rorke LBSM (2002) Atypical Teratoid/Rhabdoid tumor of the central nervous system: report on workshop. J Pediatr Haematol 24:337–342CrossRef
25.
go back to reference Quinn TJ, Almahariq MF, Siddiqui ZA et al (2019) Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: a surveillance, epidemiology, and end results analysis. Pediatr Blood Cancer:e27969. https://doi.org/10.1002/pbc.27969 Quinn TJ, Almahariq MF, Siddiqui ZA et al (2019) Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: a surveillance, epidemiology, and end results analysis. Pediatr Blood Cancer:e27969. https://​doi.​org/​10.​1002/​pbc.​27969
28.
go back to reference Rorke LB, Packer RJ, Beigal JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65CrossRefPubMed Rorke LB, Packer RJ, Beigal JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65CrossRefPubMed
29.
go back to reference Strother D (2005) Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges. Expert Rev Anticancer Ther 5:905–915CrossRef Strother D (2005) Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges. Expert Rev Anticancer Ther 5:905–915CrossRef
30.
go back to reference Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A (2005) Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose Alkylator-based chemotherapy. J Clin Oncol 23:1491–1499. https://doi.org/10.1200/JCO.2005.05.187 CrossRefPubMed Tekautz TM, Fuller CE, Blaney S, Fouladi M, Broniscer A, Merchant TE, Krasin M, Dalton J, Hale G, Kun LE, Wallace D, Gilbertson RJ, Gajjar A (2005) Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose Alkylator-based chemotherapy. J Clin Oncol 23:1491–1499. https://​doi.​org/​10.​1200/​JCO.​2005.​05.​187 CrossRefPubMed
31.
go back to reference Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, Planello AC, Zeller C, Barsyte-Lovejoy D, Lafay-Cousin L, Letourneau L, Bourgey M, Yu M, Gendoo DMA, Dzamba M, Barszczyk M, Medina T, Riemenschneider AN, Morrissy AS, Ra YS, Ramaswamy V, Remke M, Dunham CP, Yip S, Ng HK, Lu JQ, Mehta V, Albrecht S, Pimentel J, Chan JA, Somers GR, Faria CC, Roque L, Fouladi M, Hoffman LM, Moore AS, Wang Y, Choi SA, Hansford JR, Catchpoole D, Birks DK, Foreman NK, Strother D, Klekner A, Bognár L, Garami M, Hauser P, Hortobágyi T, Wilson B, Hukin J, Carret AS, van Meter T, Hwang EI, Gajjar A, Chiou SH, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheinemann K, Fleming AJ, Johnston DL, Michaud J, Zelcer S, Hammond R, Afzal S, Ramsay DA, Sirachainan N, Hongeng S, Larbcharoensub N, Grundy RG, Lulla RR, Fangusaro JR, Druker H, Bartels U, Grant R, Malkin D, McGlade C, Nicolaides T, Tihan T, Phillips J, Majewski J, Montpetit A, Bourque G, Bader GD, Reddy AT, Gillespie GY, Warmuth-Metz M, Rutkowski S, Tabori U, Lupien M, Brudno M, Schüller U, Pietsch T, Judkins AR, Hawkins CE, Bouffet E, Kim SK, Dirks PB, Taylor MD, Erdreich-Epstein A, Arrowsmith CH, de Carvalho DD, Rutka JT, Jabado N, Huang A (2016) Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors. Cancer Cell 30(6):891–908. https://doi.org/10.1016/j.ccell.2016.11.003 CrossRefPubMedPubMedCentral Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, Planello AC, Zeller C, Barsyte-Lovejoy D, Lafay-Cousin L, Letourneau L, Bourgey M, Yu M, Gendoo DMA, Dzamba M, Barszczyk M, Medina T, Riemenschneider AN, Morrissy AS, Ra YS, Ramaswamy V, Remke M, Dunham CP, Yip S, Ng HK, Lu JQ, Mehta V, Albrecht S, Pimentel J, Chan JA, Somers GR, Faria CC, Roque L, Fouladi M, Hoffman LM, Moore AS, Wang Y, Choi SA, Hansford JR, Catchpoole D, Birks DK, Foreman NK, Strother D, Klekner A, Bognár L, Garami M, Hauser P, Hortobágyi T, Wilson B, Hukin J, Carret AS, van Meter T, Hwang EI, Gajjar A, Chiou SH, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheinemann K, Fleming AJ, Johnston DL, Michaud J, Zelcer S, Hammond R, Afzal S, Ramsay DA, Sirachainan N, Hongeng S, Larbcharoensub N, Grundy RG, Lulla RR, Fangusaro JR, Druker H, Bartels U, Grant R, Malkin D, McGlade C, Nicolaides T, Tihan T, Phillips J, Majewski J, Montpetit A, Bourque G, Bader GD, Reddy AT, Gillespie GY, Warmuth-Metz M, Rutkowski S, Tabori U, Lupien M, Brudno M, Schüller U, Pietsch T, Judkins AR, Hawkins CE, Bouffet E, Kim SK, Dirks PB, Taylor MD, Erdreich-Epstein A, Arrowsmith CH, de Carvalho DD, Rutka JT, Jabado N, Huang A (2016) Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors. Cancer Cell 30(6):891–908. https://​doi.​org/​10.​1016/​j.​ccell.​2016.​11.​003 CrossRefPubMedPubMedCentral
32.
go back to reference Von Hoff K, Hinkes B, Dannenmann-Stern E, Von Bueren AO, Warmuth-Metz M, Soerensen N, Emser A, Zwiener I, Schlegel PG, Kuehl J, Frühwald MC, Kortmann RD, Pietsch T, Rutkowski S (2011) Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 57:978–985. https://doi.org/10.1002/pbc.23236 CrossRef Von Hoff K, Hinkes B, Dannenmann-Stern E, Von Bueren AO, Warmuth-Metz M, Soerensen N, Emser A, Zwiener I, Schlegel PG, Kuehl J, Frühwald MC, Kortmann RD, Pietsch T, Rutkowski S (2011) Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 57:978–985. https://​doi.​org/​10.​1002/​pbc.​23236 CrossRef
Metadata
Title
Outcomes with respect to extent of surgical resection for pediatric atypical teratoid rhabdoid tumors
Authors
Alexandra Richards
Ronak Ved
Christopher Murphy
Dawn Hennigan
John-Paul Kilday
Ian Kamaly-Asl
Conor Mallucci
Imran Bhatti
Chirag Patel
Paul Leach
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Keyword
Metastasis
Published in
Child's Nervous System / Issue 4/2020
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-019-04478-5

Other articles of this Issue 4/2020

Child's Nervous System 4/2020 Go to the issue